BioAge Current Deferred Revenue vs Common Stock Shares Outstanding Analysis
| BIOA Stock | 19.29 0.41 2.08% |
BioAge Labs, financial indicator trend analysis is way more than just evaluating BioAge Labs, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioAge Labs, is a good investment. Please check the relationship between BioAge Labs, Current Deferred Revenue and its Common Stock Shares Outstanding accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.
Current Deferred Revenue vs Common Stock Shares Outstanding
Current Deferred Revenue vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioAge Labs, Current Deferred Revenue account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have strong relationship.
The correlation between BioAge Labs,'s Current Deferred Revenue and Common Stock Shares Outstanding is 0.62. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of BioAge Labs,, assuming nothing else is changed. The correlation between historical values of BioAge Labs,'s Current Deferred Revenue and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of BioAge Labs, are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Current Deferred Revenue i.e., BioAge Labs,'s Current Deferred Revenue and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | 0.62 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from BioAge Labs,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioAge Labs, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.As of November 29, 2024, Selling General Administrative is expected to decline to about 9.2 M. In addition to that, Sales General And Administrative To Revenue is expected to decline to 0.76
| 2023 | 2024 (projected) | Interest Expense | 7.8M | 5.7M | Depreciation And Amortization | 162K | 153.9K |
BioAge Labs, fundamental ratios Correlations
Click cells to compare fundamentals
BioAge Labs, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BioAge Labs, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioAge Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioage Labs, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioage Labs, Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioAge Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.40) |
The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.